Accessing Free Eliquis Samples And Financial Assistance For Us Residents

Oct. 8, 2025, 9:54 p.m.

Tags: eliquis

Eliquis (apixaban) is a prescription medication used to treat or reduce the risk of blood clots. For many patients, the cost of this medication can be a significant financial burden. Fortunately, various programs and offers exist to help individuals access Eliquis at no cost or reduced prices. This article provides a detailed overview of the opportunities available for U.S. residents, including free samples, trial offers, co-pay assistance, and patient financial support programs. Each option is explained with its eligibility requirements, terms of use, and practical considerations to help patients make informed decisions about their medication needs.

The information presented is derived exclusively from official and verified sources, including brand-specific websites, patient assistance programs, and pharmacy support services. These resources outline the conditions under which patients can obtain free or discounted Eliquis, the duration of these offers, and any limitations or restrictions that apply. Understanding these details can help patients navigate the available options effectively and responsibly.

This article is intended for individuals seeking affordable access to Eliquis, including those with insurance, those without insurance, and those exploring financial assistance programs. The focus is on actionable information that enables patients to make informed decisions about their medication access while adhering to the terms and conditions of each offer.

Free Eliquis Samples and Trial Offers

For patients who need immediate access to Eliquis but are unable to pay the full cost of the medication, free samples and trial offers can provide a temporary solution. These offers are often available through healthcare providers or specific manufacturer programs and are designed to help patients manage their treatment without upfront costs.

One option is the Free 30-Day Trial offer provided by Bristol-Myers Squibb and Pfizer. This offer allows eligible patients to receive a free 30-day supply of Eliquis, up to 74 tablets, at participating pharmacies. To use this offer, patients must present a valid 30-day prescription from their healthcare provider and an activated Free 30-Day Trial card at the pharmacy. The trial supply is intended for patients who have not previously filled a prescription for Eliquis and are being treated for an FDA-approved indication for more than 35 days.

It is important to note that the Free 30-Day Trial offer is non-transferable and can only be used once per patient. Additionally, patients cannot combine this offer with other rebates, coupons, or trial programs. The trial is also not counted as an out-of-pocket expense for any insurance plan, including Medicare Part D, meaning it will not contribute to the patient’s deductible or out-of-pocket maximum.

The Free 30-Day Trial offer is available to U.S. residents who are 18 years of age or older and reside in the United States, Puerto Rico, or other select U.S. territories. The offer is valid until December 31, 2024, after which it will no longer be available. Patients must ensure that they activate and use the trial card before this date.

Another potential source of free Eliquis samples is through a patient’s healthcare provider. In some cases, doctors may have access to manufacturer-sponsored sample programs and can provide short-term supplies to patients who are waiting for insurance coverage to be finalized or for prior authorization to be approved. While these samples are not a long-term solution, they can help patients manage their medication needs during transitional periods.

It is recommended that patients who are considering requesting a free sample from their doctor discuss the availability of these resources and any potential restrictions that may apply. Some providers may have limited sample quantities, and others may not participate in sample programs. Understanding these factors can help patients plan accordingly and avoid potential gaps in treatment.

Co-Pay Assistance for Eliquis

For patients who are insured but still face high out-of-pocket costs for Eliquis, co-pay assistance programs can provide significant financial relief. One such program is the Eliquis Co-Pay Card, which is available to eligible patients who meet specific criteria. This card allows patients to pay as little as $10 per 30-day supply of Eliquis at participating pharmacies, up to a maximum of $6,400 annually.

To qualify for the Co-Pay Card, patients must be insured through a commercial health plan and have a co-pay obligation for Eliquis. Patients who are enrolled in state or federal healthcare programs, such as Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA), or Department of Defense (DOD) programs, are not eligible for this assistance. Additionally, patients must be at least 18 years of age and reside in the United States, Puerto Rico, or other select U.S. territories.

The Co-Pay Card is valid for up to 24 months, with the maximum benefit of $6,400 per year. Patients must present the activated Co-Pay Card along with a valid prescription for Eliquis at a participating pharmacy to receive the reduced co-pay. The program is not applicable to co-pays of $10 or less, and patients are responsible for any applicable taxes.

It is important to note that the Co-Pay Card is not health insurance and is not a substitute for insurance coverage. Patients who are considering using this program should review their insurance plan to understand how the co-pay assistance will affect their out-of-pocket costs and any potential benefits, such as deductible contributions or out-of-pocket maximums.

The Co-Pay Card is only accepted at participating pharmacies. Patients who use mail-order services or non-participating retail pharmacies should contact McKesson Pharmacy Support at 1-866-279-4730 for assistance or visit the official Eliquis website for more information on how to request a patient rebate form.

Eliquis Patient Assistance Program

For patients who do not have insurance or whose insurance does not cover the cost of Eliquis, the Eliquis Patient Assistance Program offers an alternative means of accessing the medication at a reduced cost. This program is administered by Bristol-Myers Squibb and is available to eligible patients who meet specific income and residency requirements.

To qualify for the Eliquis Patient Assistance Program, patients must be uninsured or have insurance that does not cover the medication. Additionally, patients must meet certain income eligibility requirements, which are typically based on household size and annual income. Patients must also be 18 years of age or older and reside in the United States, Puerto Rico, or other select U.S. territories.

The application process for the Eliquis Patient Assistance Program can be completed through the NiceRx platform, which assists patients in enrolling in the program and managing the application process. NiceRx offers a streamlined enrollment process in which patients provide details about their healthcare provider, insurance coverage, and household income. If a patient is determined to be eligible for assistance, NiceRx will help enroll them in the program and request their Eliquis medication refills on their behalf for up to one year.

Through the Eliquis Patient Assistance Program, eligible patients can receive the medication at a fixed cost of $49 per month. This is significantly lower than the retail price of Eliquis, which can exceed $500 for a 60-tablet pack and $830 for a 100-tablet pack when purchased without insurance. The program is intended to provide long-term support for patients who require ongoing treatment with Eliquis and who are unable to afford the medication at full retail price.

It is important to note that NiceRx is not an Eliquis coupon provider and does not offer free samples or trial offers. Instead, NiceRx serves as a facilitator for the patient assistance program and does not provide direct financial discounts or rebates for Eliquis. Patients who are interested in using this program should ensure that they understand the eligibility requirements and the application process before enrolling.

Understanding the Limitations of Eliquis Offers

While the various offers and assistance programs for Eliquis can help patients access the medication at reduced costs, it is essential to understand the limitations and restrictions that apply to each option. These limitations are outlined in the terms and conditions provided by the manufacturers and program administrators and should be carefully reviewed to ensure compliance and avoid potential issues.

One key limitation of the Free 30-Day Trial offer is that it cannot be combined with any other rebates, coupons, or trial programs. This means that patients who have access to other forms of financial assistance for Eliquis, such as co-pay cards or patient assistance programs, cannot use those benefits in conjunction with the Free 30-Day Trial. Additionally, patients cannot seek reimbursement for the trial offer from health insurance or any third-party programs, including state or federally funded initiatives.

The Free 30-Day Trial is also not counted as an expense for the purposes of determining out-of-pocket costs for any insurance plan. This includes the Medicare Part D TrOOP (True Out-of-Pocket) threshold, which is used to determine when a beneficiary reaches the catastrophic coverage phase of the Medicare Part D benefit. As a result, patients who use the Free 30-Day Trial may not see any impact on their insurance-related costs or benefits.

Another important consideration is that the Free 30-Day Trial offer is limited to one use per patient and is non-transferable. This means that once a patient has used the trial, they are not eligible to use it again, and they cannot share or transfer the offer to another individual. Patients who have previously filled a prescription for Eliquis are also not eligible for the trial offer.

For the Co-Pay Card, patients should be aware that the program is not applicable to co-pays of $10 or less. This means that if a patient’s co-pay for Eliquis is already $10 or lower, they will not receive any additional benefit from the Co-Pay Card. Additionally, the Co-Pay Card is not valid for prescriptions written for more than 30 days, so patients who require longer-term prescriptions will need to use the card for multiple fills.

The Co-Pay Card also has a maximum annual benefit of $6,400, which is distributed over 24 months. Patients should calculate their expected out-of-pocket costs for Eliquis to determine whether the Co-Pay Card will provide sufficient financial relief for their needs. Patients who exceed the maximum benefit may need to explore other forms of assistance or consider alternative treatment options.

For the Eliquis Patient Assistance Program, patients should be aware that the program is not a long-term solution and is typically available for a period of one year. Patients who require ongoing treatment with Eliquis may need to reapply for assistance or explore other financial support options. Additionally, the program is not available to patients who are enrolled in state or federal healthcare programs, which may limit its availability for certain individuals.

Practical Considerations for Patients

When considering the various options for accessing Eliquis at no cost or reduced prices, patients should take several practical considerations into account. These include the duration of the offers, the eligibility requirements, the pharmacy participation, and the potential impact on insurance coverage.

One of the most important considerations is the expiration dates of the offers. The Free 30-Day Trial offer is valid until December 31, 2024, after which it will no longer be available. Patients who are interested in using this offer should ensure that they activate and use the trial card before this date. The Co-Pay Card is valid for up to 24 months, but patients should review the terms to understand how often they can use the card and whether there are any restrictions on the number of refills.

Patients should also consider the pharmacy participation for each offer. The Free 30-Day Trial and Co-Pay Card are only accepted at participating pharmacies, which may limit the availability of these programs for patients who use non-participating pharmacies or mail-order services. Patients who are unsure whether their pharmacy participates in these programs should contact the pharmacy directly or reach out to McKesson Pharmacy Support at 1-866-279-4730 for assistance.

Another important consideration is the impact on insurance coverage. Patients who use the Free 30-Day Trial offer should understand that this will not affect their insurance-related costs or benefits. This includes the deductible, out-of-pocket maximum, and TrOOP threshold for Medicare Part D plans. Patients who are using the Co-Pay Card should also review their insurance plan to understand how the reduced co-pay will affect their out-of-pocket costs and any potential benefits.

Patients should also consider the long-term availability of each program. The Free 30-Day Trial is a one-time offer and is not available for future prescriptions. The Co-Pay Card is available for up to 24 months, but patients may need to reapply for assistance after this period. The Eliquis Patient Assistance Program is typically available for up to one year, after which patients may need to reapply or explore other financial support options.

Finally, patients should be aware that the manufacturers and program administrators reserve the right to change or terminate the offers at any time. This means that the availability of these programs may change in the future, and patients should stay informed about any updates or modifications to the terms and conditions.

Conclusion

Accessing Eliquis at no cost or reduced prices is possible through various programs and offers, including free samples, trial offers, co-pay assistance, and patient financial support. These options provide valuable opportunities for patients who are unable to afford the medication at full retail price. However, it is essential to understand the eligibility requirements, terms of use, and limitations of each program to make informed decisions about medication access.

Patients should carefully review the information provided by the manufacturers and program administrators to ensure that they meet the criteria for each offer. Additionally, patients should consider the duration of the offers, pharmacy participation, and potential impact on insurance coverage when choosing the most appropriate option for their needs.

By exploring the available programs and understanding the associated terms and conditions, patients can effectively manage their Eliquis treatment and reduce the financial burden associated with this medication.